Latest Ratios: P/E Ratio -2.4x · EV/EBITDA N/A · ROE -75.4%. (2011–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $74M | $77M | $92M | $315M | $32M | — | — | — | — | — | — |
| Enterprise Value | $48M | $52M | $87M | $295M | $32M | — | — | — | — | — | — |
| P/E Ratio → | -2.36 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 796.67 | 833.89 | 137.89 | — | — | — | — | — | — | — | — |
| P/B Ratio | 1.26 | 1.47 | 4.18 | 41.02 | 11.50 | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 560.10 | 130.09 | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -64.3% | -64.3% | 39.8% | — | — | -2302.4% | -454.2% | -1083.4% | -542.7% | -383.8% | -1538.7% |
| Operating Margin | -34221.4% | -34221.4% | -6574.2% | — | — | -34363.7% | -5466.0% | -8213.8% | -5878.5% | -3197.5% | -9930.2% |
| Net Profit Margin | -30392.8% | -30392.8% | -6331.8% | — | — | -27095.0% | -4869.3% | -12096.9% | -8450.0% | -3909.6% | -11919.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -75.4% | -75.4% | -284.6% | -777.8% | -302.2% | -606.8% | — | — | — | — | — |
| ROA | -38.6% | -38.6% | -83.3% | -165.5% | -136.1% | -220.4% | -115.4% | -184.9% | -146.2% | -137.2% | -137.7% |
| ROIC | -107.9% | -107.9% | -1298.8% | — | -293.8% | -1428.6% | — | — | — | -527.8% | -407.5% |
| ROCE | -50.6% | -50.6% | -97.6% | -207.2% | -339.6% | -621.4% | — | — | — | — | -731.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.20 | 0.20 | 0.47 | 1.32 | 0.01 | 0.02 | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.48 | -0.24 | -2.53 | -0.09 | -0.03 | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -38.90 | -14.87 | -2.62 | -1.76 | -1.68 | -2.73 | -2.69 |
Net cash position: cash ($36M) exceeds total debt ($11M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.56 | 2.56 | 2.86 | 5.03 | 0.12 | 0.06 | 0.13 | 0.09 | 0.03 | 0.10 | 0.12 |
| Quick Ratio | 2.52 | 2.52 | 2.77 | 5.03 | 0.12 | 0.06 | 0.13 | 0.08 | 0.01 | 0.07 | 0.04 |
| Cash Ratio | 2.43 | 2.43 | 2.73 | 5.00 | 0.10 | 0.02 | 0.11 | 0.07 | 0.00 | 0.05 | 0.01 |
| Asset Turnover | — | 0.00 | 0.01 | — | — | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 | 0.01 |
| Inventory Turnover | 0.30 | 0.30 | 0.81 | — | — | — | 11.13 | 12.10 | 3.80 | 5.37 | 2.77 |
| Days Sales Outstanding | — | 4221.96 | 26.09 | — | — | 638.82 | 313.00 | — | 444.85 | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — |
| Shares Outstanding | — | $18M | $15M | $10M | $5M | $4M | $2M | $1M | $294064 | $102267 | $25802 |
Pre-revenue development execution risk
According to recent market data, ATLX trades at a P/S ratio of 805.43, a figure that appears disconnected from fundamental performance and instead reflects investor anticipation of future spodumene production milestones rather than any current ability to generate meaningful top-line revenue from its mineral assets.
The extreme P/S multiple suggests that the market is pricing in a 'fast-follower' premium, assuming the company will successfully replicate the permitting and production success of local peers. Investors should note that such high valuations are inherently fragile, as they rely entirely on the successful execution of the Neves Project and are highly sensitive to any delays in the regulatory timeline.
Based on reported figures, ATLX's ROIC has remained deeply negative, reaching -44.7% in 2026Q1, which underscores the company's current inability to generate returns on invested capital while it remains in the capital-intensive, pre-revenue phase of its lithium development cycle in the Minas Gerais region.
The persistent decay in ROIC is a direct consequence of heavy spending on exploration and feasibility studies without a corresponding revenue stream. This trend warrants further investigation, as it indicates that the company is currently destroying shareholder value through capital deployment that has yet to reach a commercial inflection point.
As reported in financial statements, the company's CCC has remained consistently negative, with DSO figures reaching as high as 3,273 days in 2025Q4, which highlights the extreme difficulty in managing working capital cycles while the business lacks a stable, recurring revenue-generating engine for its lithium operations.
The erratic nature of these efficiency metrics is typical for a firm transitioning from legacy mineral sales to a pure-play lithium developer. The lack of operational leverage suggests that management's focus remains on project definition rather than optimizing the cash conversion cycle, which is unlikely to improve until commercial production commences.
Based on quarterly filings, ATLX has maintained a D/E ratio of 0.20 as of 2026Q1, suggesting that while the company has avoided excessive debt, its reliance on equity financing to fund operations leaves it vulnerable to dilution risks during periods of high capital consumption.
The company's interest coverage remains negative, reflecting the lack of operating income to service even modest debt obligations. Investors should monitor the company's ability to secure non-dilutive financing, as continued reliance on equity markets may further erode the value of existing shares if project timelines are extended.
The P/S ratio is frequently misapplied to ATLX, as the company's current revenue is derived from non-core legacy assets rather than its primary lithium business, rendering this metric an unreliable indicator of the company's true long-term value or its potential for future spodumene production.
Analysts should instead focus on the Net Present Value (NPV) of the Neves Project and the company's cash burn rate relative to its remaining liquidity. Using P/S to value a pre-revenue developer obscures the fundamental risks associated with permitting, resource grade, and the eventual cost of capital required to build the processing infrastructure.
Includes 30+ ratios · 15 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ATLX stock.
Atlas Lithium Corporation's current P/E ratio is -2.4x. This places it at the 50th percentile of its historical range.
Atlas Lithium Corporation's return on equity (ROE) is -75.4%. The historical average is -175.9%.
Based on historical data, Atlas Lithium Corporation is trading at a P/E of -2.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Atlas Lithium Corporation has -64.3% gross margin and -34221.4% operating margin.